Enovis (ENOV) director Christine Ortiz receives 846-share stock award

Rhea-AI Filing Summary

Ortiz Christine reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Christine Ortiz received an equity award of 846 shares of common stock. The shares were granted on June 30, 2026 at a stated price of $0.00 per share as a compensation-related award rather than a market purchase.

Following this grant, Ortiz directly holds 25,857 shares of Enovis common stock. This filing records a routine non-derivative stock award to a board member, with no associated open-market buying or selling activity.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Ortiz Christine

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common stock, par value $0.001	846	$0.00	--

Holdings After Transaction: Common stock, par value $0.001 — 25,857 shares (Direct, null)

Footnotes (1)

Key Figures

Stock award size: 846 shares Award price per share: $0.00 per share Holdings after transaction: 25,857 shares +1 more

4 metrics

Stock award size 846 shares Common stock grant on June 30, 2026

Award price per share $0.00 per share Stated transaction price for granted shares

Holdings after transaction 25,857 shares Total Enovis common stock directly held after grant

Transaction count 1 acquisition Non-derivative grant, award, or other acquisition

Key Terms

Common stock, par value $0.001, Grant, award, or other acquisition, non-derivative, Form 4

4 terms

Common stock, par value $0.001 financial

"security_title: Common stock, par value $0.001"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

non-derivative financial

"transaction_type: non-derivative"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/01/2026 - 09:00 PM Accepted by SEC EDGAR 07/01/2026 - 09:00 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Ortiz Christine

(Last) (First) (Middle)

2711 CENTERVILLE ROAD

SUITE 400

(Street)

WILMINGTON DELAWARE 19808

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Enovis CORP [ ENOV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.001	06/30/2026		A		846	A	$0.00	25,857	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Brian P. Hanigan, attorney-in-fact	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Enovis (ENOV) director Christine Ortiz report in this Form 4 filing?

Christine Ortiz reported receiving 846 shares of Enovis common stock as a stock award. The transaction is coded as a grant or other acquisition, reflecting compensation rather than a market trade, and increases her direct holdings to 25,857 shares after the transaction.

Was the Enovis (ENOV) insider transaction by Christine Ortiz a stock purchase or a grant?

The transaction was a stock grant, not an open-market purchase. It is coded as a “Grant, award, or other acquisition” with a price of $0.00 per share, indicating compensation-related equity rather than buying shares in the market.

How many Enovis (ENOV) shares does Christine Ortiz hold after this reported grant?

After receiving the 846-share award, Christine Ortiz directly holds 25,857 shares of Enovis common stock. This total reflects her position immediately following the transaction reported in the Form 4, giving investors a snapshot of her updated equity stake.

What is the size of Christine Ortiz’s Enovis (ENOV) stock award reported on June 30, 2026?

The award consists of 846 shares of Enovis common stock granted on June 30, 2026. The filing lists a transaction price of $0.00 per share, consistent with a standard equity compensation grant to a director rather than a cash-funded share purchase.

Does the Enovis (ENOV) Form 4 for Christine Ortiz show any stock sales?

The Form 4 does not show any stock sales by Christine Ortiz. It reports only one non-derivative transaction: an acquisition of 846 shares through a grant or award, with no dispositions or derivative exercises included in the summarized activity.